These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 16540761
1. Natural history of nonalcoholic steatohepatitis. Liou I, Kowdley KV. J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761 [Abstract] [Full Text] [Related]
2. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228 [Abstract] [Full Text] [Related]
3. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH. Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341 [Abstract] [Full Text] [Related]
4. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. McCullough AJ. Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061 [Abstract] [Full Text] [Related]
5. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J. Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117 [Abstract] [Full Text] [Related]
9. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P. Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [Abstract] [Full Text] [Related]
10. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, Fisher RA, Ham J, Sanyal AJ. Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298 [Abstract] [Full Text] [Related]
11. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Rubinstein E, Lavine JE, Schwimmer JB. Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294 [Abstract] [Full Text] [Related]
12. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F. Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485 [Abstract] [Full Text] [Related]
13. The natural history of non-alcoholic fatty liver disease. Caldwell S, Argo C. Dig Dis; 2010 Mar; 28(1):162-8. PubMed ID: 20460906 [Abstract] [Full Text] [Related]
14. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH. Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K. J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489 [Abstract] [Full Text] [Related]
15. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Serfaty L, Lemoine M. Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623 [Abstract] [Full Text] [Related]
16. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Malik SM, Gupte PA, de Vera ME, Ahmad J. Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869 [Abstract] [Full Text] [Related]
17. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Cotrim HP, Paraná R, Braga E, Lyra L. Am J Gastroenterol; 2000 Oct; 95(10):3018-9. PubMed ID: 11051414 [No Abstract] [Full Text] [Related]
18. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. Ong JP, Younossi ZM. Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567 [Abstract] [Full Text] [Related]